Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio? – Akero Therapeutics (NASDAQ:AKRO), Brinker International (NYSE:EAT)

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?

1. Akero Therapeutics, Inc. AKRO shares surged 106.57% after the company reported preliminary Week 96 results from its SYMMETRY Phase 2B study of Efruxifermin. Several analysts boosted the price forecast.
2. Surgery Partners, Inc. SGRY stock increased 25.44%  after the company announced it received a non-binding acquisition proposal from Bain Capital Private Equity.
3. Flagstar Financial, Inc. FLG shares rose 24.40% fter the company reported better-than-expected financial results. Barclays analyst Jared Shaw maintained an Overweight and raised the price forecast from $13 to $14.
4. Nextracker Inc. NXT shares escalated 22.98% after the company reported better-than-expected 2025 fiscal-year third-quarter financial results and raised its guidance. Several analysts revised the price forecast.
5. Brighthouse Financial, Inc. BHF shares are up 21.76% following a report suggesting that the company is exploring a potential sale. Barclays analyst Alex Scott upgraded the company from Equal-Weight to Overweight and raised the price forecast from $52 to $85.
6. Brinker International, Inc. EAT stock upped 21.72% after the company reported better-than-expected second-quarter results and several analysts changed their price forecasts.
7. Hims & Hers Health, Inc. HIMS shares were up 20.76%.
8. Oshkosh Corporation OSK shares surged 19.38% after the company beat fourth-quarter estimates, initiated FY25 EPS guidance above expectations, and raised its quarterly dividend by 11%. Analysts boosted the price forecast on the stock.
9. Kingsoft Cloud Holdings KC stock upped 16.50%, probably due to the Lunar New Year, recent AI developments in China and government efforts to boost markets.
10. Viavi Solutions Inc. VIAV stock jumped 14.78% after the company reported better-than-expected second-quarter financial results.

Read Next:

Photo via Shutterstock